chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received anthrax and influenza vaccines on the same day with mild local reactions. Her LMP prior to conception was in October 1998. She became pregnant approximately 1 month after receipt of the vaccines (Estimated date of conception was between 12 and 15 November).  Pregnancy was diagnosed around November 20th.  Her due date was 8/15/99.  She delivered a baby boy on 8/8/99. Her son, who is now 4, was just diagnosed with high level functioning autism. (A separate VAERS report will be filed on him, listing his vaccine history and onset of symptoms.)
Pt reported swelling of the arm from the injection site to his lower arm near his inner elbow. Pt also experienced tachycardia later that evening.
I have gotten the flu shot for years and usually have arm pain for a day or two after and then it subsides. This time the pain started in the afternoon of the shot and got so bad I couldn't lift my arm. The pain did not go away within a few days and has proceeded to get worse 6 weeks later. My arm is weak, the pain is causing trouble sleeping for the past few weeks. I can't lift my arm without pain and activities have been limited (including getting dressed and driving). The pain is in my upper arm that I got the shot in and started the afternoon of the shot. Pain is sometimes in muscle and others closer to the shoulder. I tried Aleve, Advil, Tylenol, etc but none helped. Went to my Primary care who recommended starting with physical therapy. If it's not better I am scheduled for an MRI on 12/12. PMC said that the injection could have been too high in either the joint or bursa, but not 100%.
Information has been received from a registered nurse referring to an unspecified number of patients. Sometime in the month of February 2015, the patients were vaccinated with improperly stored PROQUAD (Merck) (lot #, dose and route were not reported). No symptoms reported. This is one of reports received from the same reporter. Additional information has been requested.
Left side of face is swollen (slight) as compared to the right side; Feels numb as if coming out of novacaine, and feeling is not as sharp as right side.; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7533), via an unspecified route of administration in the left arm on 05May2021 at 09:30 (at the age of 47-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had known allergies which included crustaceans. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05May2021, the patient experienced left side of face is swollen (slight) as compared to the right side where the patient can see the cheek bone. Feels numb as if coming out of novacaine, and feeling was not as sharp as right side. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events left side of face is swollen (slight) as compared to the right side where the patient can see the cheek bone and feels numb as if coming out of novacaine, and feeling is not as sharp as right side were not resolved at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Felt very hot after getting vaccine: drinking water> Then tasted metallic taste; BP slightly elevated 160/90; no other issues.Monitored; hot resolving, metal taste resolving
Per facility, patient received Moderna COVID-19 vaccine on 3/10/2021 and Pfizer COVID-19 vaccine on 9/25/2021 and was subsequently diagnosed at our hospital with COVID-19
NO ADVERSE  REACTION. FOR ERROR COVID VACCINE ADMINISTER  16 YRS  YOUNG MAN. NO SIDE EFECTS, NO ALLERGIES, NO PROBLE.  MOTHER SAID EVERYTHING IS WELL AND IS REQUIRING THE SECOND DOSE BUT I EXPLAIN IT HAS TO WAIT FOR PERMISION.
2 hrs p/vax pt woke screaming incontrollably x 45 mins; mom stated pt was purple from umbilicus to toes; color returned to nl in 30 mins & PE was nl 1 hr later;
Patient received injection at 14:05 at 14:12 he reported not feeling well. Patient was diaphoretic, clammy, pale, described the inability to see, had difficulty following commands. Patient transferred to gurney with max assist and transferred to E.R. Patient symptoms resolving during transport. Left patient in E. R. care at 14:15.
About 10 min after receiving first dose of Pfizer COVID vaccine, pt had vasovagal response and fell to floor. Hit cheek on floor, and was very scared of event, but returned to baseline in a minute or two. Cold towel applied to left cheek and educated mother to take pt to be evaluated if cheek continues to hurt after applying ice at home. After waiting an additional 10 min, pt able to walk out of clinic waiting area with mother.
KINRIX was given at 4 month well check and is not recommended in children under 4 years of age.
Thursday pm I began to experience palpitations, indigestion, substernal pain, and back pain between the shoulder blades when breathing deeply. Friday the symptoms continued, particularly in the evening. I began monitoring my blood pressure Friday evening with the electronic arm cuff that we normally use. It is staying abnormally low, ranging between 105/68 - 109/70 on 4 different measures. My normal range stays between 115/78 at the lowest - 130/90 at the highest.  Today, all symptoms remain unchanged and blood pressure remains <110/70
Patient received moderna vac covid 19 at 4:38p in left arm. Pt was instructed to wait for 15 minutes as she answered "no" to any allergies. After the 15 minutes were up, patient continued to shop. She came back to the pharmacy around 5:08pm, complaining of feeling itching without any visible symptoms. Patient was provided with  benadryl (diphenhydramin) 50mg (approx 5:10pm) as she stated her weight was over 100 Ibs. I observed pt and started to discuss with patient signs of generalized anaphylaxis, at which time patient informed me that she did have food allergies but did not think it was important to put on the form as she is not even sure what she is allergic to.  Approx 5:16pm , pt stated she felt face swelling. Associate was instructed to call 911 immediately and inform mgmt of code white and location. One dose of epinephrine 0.3mg was administered intramuscularly in patient's left thigh. Patient was observed and around 5:21pm, pt stated she had no more anaphylaxis reactions occurring. Approx 5:25pm, EMS arrived at which time patient was stable. Patient's vitals were stable, and EMS recommended for pt to be seen in the ER for further evaluation.  Pt was placed on stretcher and wheeled out by EMS at aprox 5:40pm.
vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) in a 23-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was in August 2020 and the estimated date of delivery was 07-May-2021. On 24-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 24-Feb-2021, EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2020, Pregnancy test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment details were reported.
Swollen area between shoulder and neck; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Apr2021 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medication was not reported. On an unknown date in Apr2021, the patient experienced a swollen area between shoulder and neck. The clinical outcome of the event swollen area between shoulder and neck was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
7:00 PM: Onset of dizziness, extreme sense of panic (anxiety), Onset of nausea, mild lethargy 9:00 PM: Severe/persistent dizziness, severe/persistent nausea, increased lethargy 11:00 PM: Vomiting, Diarrhea, Stomach Pains, Fever of 101 degrees, increased/severe dizziness, confusion, lethargy. 12-2:00 AM: Severe dizziness, Continuing fever, increased confusion, increased lethargy, continued vomiting/diarrhea, severe joint pain and muscle aches, muscle spasms.  1/18/2010 11:00 AM: Symptoms from 1/17/2010 continuing with no relief, muscle spasms more frequent, body aches more frequent, fever continues. 1/19/2010: Continuing of above symptoms, fever downgrades to 100 degrees. 1/20/2010: Relief of symptoms.
aware of 6 cases of Bell's Palsy by the companies making these vaccines; This is a spontaneous report from a contactable other health professional (HCP). This other HCP reported similar events for 6 patients. This is the 5th of 6 patient. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter reported since the use of modified RNA in covid vaccines, he/she had aware of 6 cases of Bell's Palsy by the companies making these vaccines since an unknown date. The outcome of the event was unknown.  Information about batch/lot number has been requested.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the event facial paralysis cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021007605 Different patient, same drug/event.
Three hours after the vaccine I had nausea and  tiredness, slept for five hours. After waking up, I've had muscle ache, high fatigue and weakness,  soreness all over the body,  headache, head pressure, and pain in my muscles when an area of my body is pressed or grasped. Yesterday at 4pm, had chills and temperature for a total of 4 to five hours.
extremely high blood pressure; Test: PCR, Result: positive; COVID 19; Swollen lymphnodes in left side arm pit; lumps in breasts about 1.5 weeks after booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 12Nov2021 17:00 (Lot number: FG3527) at the age of 42 years as dose 3 (booster), single, administered in arm left, administration date 23Mar2021 12:00 (Lot number: El3248) as dose 2, single and administered in arm left, administration date 03Mar2021 12:00 (Lot number: EL3248) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Cephalosporins, reaction(s): "Known allergy: Cephalosporins", notes: Known allergy: Cephalosporins. The following information was reported: VACCINATION FAILURE (medically significant) with onset 22Dec2021, outcome "unknown", described as "Test: PCR, Result: positive"; COVID-19 (medically significant) with onset 22Dec2021, outcome "unknown", described as "COVID 19"; HYPERTENSION (hospitalization) with onset 08Dec2021, outcome "recovered" (2022), described as "extremely high blood pressure"; LYMPHADENOPATHY (non-serious) with onset 23Nov2021, outcome "unknown", described as "Swollen lymphnodes in left side arm pit"; BREAST MASS (non-serious) with onset 23Nov2021, outcome "unknown", described as "lumps in breasts about 1.5 weeks after booster". The patient was hospitalized for hypertension (start date: 08Dec2021). The event "extremely high blood pressure" was evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: blood pressure measurement: (08Dec2021) 200/100, notes: 200/100; full blood count: (03Jan2022) normal, notes: showed 99egfr ( so back to normal); phaeochromocytoma: (22Dec2021) normal, notes: normal; sars-cov-2 test: (22Dec2021) positive, notes: Nasal swab. Therapeutic measures were taken as a result of hypertension. Clinical Course : Swollen lymphnodes in left side arm pit and lumps in breasts about 1.5 weeks after booster , then on 08Dec extremely high blood pressure event above 200/100 and went to ER. All lab tests were normal although note that egfr was 70. Went to GP and got put on HBP meds - losarten with hydrochlorothiozide added on later . Took about 7 days to regulated BP to normal and then followed up with a cardio visit on 03Jan and blood work. Cardio visit ok and however blood work showed 99egfr (so back to normal) was also tested for pheo and it was all normal. There is not clarity on what drove the high blood pressure event from the specialist or GP, except I am back to normal now but on meds for HBP. I wanted to report I case it was booster related. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19.
Localized redness, swelling,hot to touch. At injection site. Nausea,  diaphoresis , moderate joint pain, moderate muscle pain, fatigue.
PARENT REPORTED 1 X 2 INCH AREA OF REDNESS AT VACCINE SITE. NO STREAKING, NOT WARM TO TOUCH, AFEBRILE. DISCUSSED COMFORT MEASURES AND PLAN IF FOLLOW-UP BECOMES NECESSARY.
This medically confirmed spontaneous report (initial receipt: 13-Sep-2012) concerns a 46-year-old male patient. Concomitant medication included atorvastatin. On 11-Sep-2012 the patient received AFLURIA (batch number: P58507) injection at a dose of 0.5 (mL) once intramuscularly. On 11-Sep-2012, after receiving AFLURIA, the patient developed a high fever. He contacted the pharmacist. Treatment included acetaminophen. The event outcome was recovering.
PAIN SPREAD THROUGHOUT THE SHOULDER; LEFT ARM PAIN; This spontaneous report received from a patient concerned a 72 year old. The patient's height, and weight were not reported. The patient's concurrent conditions included shoulder hurting, and neck hurting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, expiry: UNKNOWN) dose was not reported, administered on 22-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 22-MAR-2021, the subject experienced pain spread throughout the shoulder. On 22-MAR-2021, the subject experienced left arm pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain spread throughout the shoulder, and left arm pain. This report was non-serious.
About 10 minutes after giving patient the shot, his mom told me he passed out on his chair. I came to the waiting room to check on patient while he was waking up. He was out for about 1 minute per his mother. His skin was warm, pulse steady.  He said a few minutes after getting the shot, he felt dizzy and fainted. He was not hurt as he was sitting down .  I gave him a bottle of water and let him rest.  After 15 minutes patient was well enough to leave with his mother.  I called to check on him 1 hour later and his mother said he was fine.
The sciatica started on the 24th of January. I experienced a lot of excruciating pain. I went to the emergency room on the 26th. I was sent home with the hydrocodone and prednisone prescriptions.
Started on Sunday, November 7 with dizziness the feeling of passing out. On November 9 ended up in the ER all day. CT scans ran everything OK. Bloodwork done everything fine. Still have the dizziness heart rate was dropping pulse rate going up. Was sent home told to drink plenty of fluids. They really didn?t think it was the shot but it was a coincidence that it happened I had the test on Friday this started on Sunday.
Day 1-2 after injection local rx red warm to touch. Rx faded. 1/13/13 injection site red warm to touch again, pt feeling fatigued. 1/14/13 - Rx improved, less fatigue, injection site redness fading.
Information has been received from a Registered Pharmacist concerning a female child patient who on 09-NOV-2010 was vaccinated with a dose of VARIVAX (Merck) (Lot# unknown) from an unknown provider. The pharmacist reported that on 11-NOV-2010, the patient developed blisters. At the time of the report, the outcome of the patient was unknown. It was unknown if the patient sought medical attention. Additional information has been requested.
24 hours of low grade fever ranging 99.6 -100.8, chills, body aches, fatigue. Symptoms lasted about 24 hours. Treated with Tylenol and ibuprofen. Fine 48 hours after vaccine.
Information has been received from a registered nurse referring to unspecified number of patients of unknown age and gender. The patients' medical history and drug allergies were not reported. On unknown dates the patients were vaccinated with improperly stored GARDASIL (lot# K008931 with expiration date of 04-MAR-2017) (strength, dose and route unknown). No adverse effects reported. No product quality complaints (PQC) involved. This is one of several reports received from the same reporter. Additional information has been requested.
VACCINE HAD A BEYOND-USE-DATE OF 06/30/2023 AND WAS ADMINISTERED ON 07/03/2023; CONTACTED MODERNA AND THEY RESPONDED THAT THE VACCINE ADMINISTERED MAINTAINED THE ACTIVITY NECESSARY TO PROTECT AGAINST THE SARS-CoV-2 (COVID-19) VIRUS AT THE TIME OF ADMINISTRATION, THE CASE ID IS MI-00034087
Child had chicken pox. Father had shingles one week before child broke out. Child had more than 30 pox on entire body.
The pt experienced his left eyelid not closing as often or as briskly, drooping of the left side of his lip, numbness in left cheek, left side of face. Tongue protrudes, pulls to left. The pt was diagnosed with Bell's Palsy, treated with Prednisone.
On 07/24/02 L deltoid area started getting red and swollen. On 07/26/02 redness and swelling extends from L shoulder down arm to left wrist. Entire arm reddish-purple. Was seen by MD on 07/26/02. Tx with Decadron 2mg IM. Cont with Benadryl and cool compresses.
bilateral pneumonia required ICU admission required 6 liters of oxygen, all cultures , viral pathogens screen, blood and sputum were negative
This case was reported by a healthcare professional and described the occurrence of dizziness in a 23-year-old male subject who was vaccinated with ENGERIX B (GlaxoSmithKline). Concurrent medical conditions included aortic insufficiency and a family history of heart disease. There were no concurrent medications. On 17 April 2011 at 14:30 the subject received 2nd dose of ENGERIX B (adult) in the left deltoid. On 17 April 2011, immediately after vaccination with ENGERIX B, the subject experienced dizziness, pallor and pulse decreased (systolic pressure was 80). The nurse practitioner believed that the subject had a vasovagal response to receiving vaccination. At the time of reporting the outcome of the events was resolved, however, outcome for vasovagal response was not specified. The reporter felt that the events were attributable to treatment with ENGERIX B.
RENAL FAILURE; ORGAN FAILURE; Deterioated quickly; This spontaneous report was received from a nurse via company representative refers to a 40 year old female patient (nurse's cousin). The patient's concurrent condition included pulmonary hypertension. The patient's medical history, concomitant medication, drug reactions and allergies were not reported. It was reported that the patient was awaiting for a heart and double lung transplant. On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and hepatitis a vaccine, inactivated (manufacturer unknown) (strength, dose, route of administration, anatomical location, lot# and expiration date was not reported for both the suspect therapies) for prophylaxis. The vaccines were reconstituted with sterile diluent (MERCK STERILE DILUENT) (strength, dose, indication, route of administration, lot# and expiration date was not reported). On an unknown date after receiving the vaccines, the patient experienced quick deterioration and went into organ and renal failure (organ failure, general physical health deterioration and renal failure). On 10-FEB-2020, the patient died. It was unknown if an autopsy was performed. The cause of death was not reported. Causality was not reported. No product quality complaint (PQC) was involved with this report.  Upon internal review, the event of renal failure was determined to be medically significant.
Red spot appeared on back of tongue.  No pain or loss of taste associated with it.  Tongue just looks smooth in that area.
Frequent urination Insomnia ( unrelated to frequent urination)  Feelings of severe dehydration  Muscle ache  Headache
The patient experienced redness and swelling with Pneumovax; The patient experienced redness and swelling with Pneumovax; This spontaneous report was received from a nurse regarding a female patient of unknown age and gender. Information on patient's concurrent conditions, medical history and concomitant medications were not reported. On 11-OCT-2010, the patient was vaccinated with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) (dose, strength, anatomical location, route, lot# and expiry date were not reported) for prophylaxis. On an unknown date, the patient experienced redness (erythema) and swelling with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23). It was reported that no other vaccination were given at this time of injection with prepping 13.The outcome of the events was unknown.The causality assessment was related.
same day of vaccination red spot at vaccination site-lasted two days then went away; 2/7/21 red spot came back and was hard/warm to the touch